From Immediate-Release MPH to OROS MPH: The Impact Upon Family of Children and Adolescents With ADHD.
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2015
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Johnson & Johnson
- 07 Apr 2014 Primary endpoints were added as reported by ClinicalTrials.gov record.
- 28 Apr 2010 Actual patient number (297) added as reported by ClinicalTrials.gov.
- 10 Jun 2009 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.